Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy.
Publication
, Journal Article
Hylek, EM; Becker, RC
Published in: Annals of neurology
November 2008
Duke Scholars
Published In
Annals of neurology
DOI
EISSN
1531-8249
ISSN
0364-5134
Publication Date
November 2008
Volume
64
Issue
5
Start / End Page
480 / 483
Related Subject Headings
- Vitamin K
- Stroke
- Risk Assessment
- Phenotype
- Neurology & Neurosurgery
- Intracranial Thrombosis
- Humans
- Dose-Response Relationship, Drug
- Cerebral Hemorrhage
- Blood Coagulation
Citation
APA
Chicago
ICMJE
MLA
NLM
Hylek, E. M., & Becker, R. C. (2008). Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy. Annals of Neurology, 64(5), 480–483. https://doi.org/10.1002/ana.21551
Hylek, Elaine M., and Richard C. Becker. “Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy.” Annals of Neurology 64, no. 5 (November 2008): 480–83. https://doi.org/10.1002/ana.21551.
Hylek EM, Becker RC. Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy. Annals of neurology. 2008 Nov;64(5):480–3.
Hylek, Elaine M., and Richard C. Becker. “Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy.” Annals of Neurology, vol. 64, no. 5, Nov. 2008, pp. 480–83. Epmc, doi:10.1002/ana.21551.
Hylek EM, Becker RC. Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy. Annals of neurology. 2008 Nov;64(5):480–483.
Published In
Annals of neurology
DOI
EISSN
1531-8249
ISSN
0364-5134
Publication Date
November 2008
Volume
64
Issue
5
Start / End Page
480 / 483
Related Subject Headings
- Vitamin K
- Stroke
- Risk Assessment
- Phenotype
- Neurology & Neurosurgery
- Intracranial Thrombosis
- Humans
- Dose-Response Relationship, Drug
- Cerebral Hemorrhage
- Blood Coagulation